by Kristina Campbell
Teams of scientists from around the world envisage new solutions and methods for treating and preventing different kinds of allergic diseases, thanks to our gut microbiota and its preventive role.
Beyond genetics and lifestyle, the gut microbiome is now emerging as an important factor in cancer progression and treatment response. This raises an important question: could understanding and targeting this ecosystem transform the way we treat cancer?
The fifth edition of IBS Days delved into the latest developments in IBS research and clinical management. This article aims to explore causes that can be misdiagnosed as IBS and non-pharmacological strategies targeting gut barrier and gut microbiome dysfunction.
Bifidobacteria are increasingly studied as a marker of gut health across a lifetime. In this interview, microbiome researcher Sudarshan Shetty explains what shapes them, how they change with age, and what diet can do.
Crohn’s disease is an inflammatory bowel disease linked to an imbalance in the gut microbiome. Now, researchers at McMaster University have found in mice a way to target and 'turn off' only the bad gut bacteria using specially trained, precision viruses. This breakthrough paves the way for treatments tailored to each patient.
by Cristina Sáez
A new study identifies two common gut microbes that work together to degrade mucin, a key lubricant for stool movement. This mechanism may explain why many treatments fail to provide lasting relief. The findings could pave the way for personalized therapies and new diagnostic biomarkers.
by Andreu Prados
While diet is a major determinant of the human gut microbiome, little is known about diet-microbiome associations at species-level resolution. New findings from the Human Phenotype Project found species-level, food-specific associations validated at population scale that might guide personalized nutrition.
What do the soil under our feet, the pets in our homes, and the microbes in fermented foods all have in common? They are all part of the same vast microbial web, and they all help shape your gut.
by Andreu Prados
Digestive symptoms with an impact on quality of life (QoL) affect one in four adults in the general population worldwide who do not qualify for a diagnosis of a Disorder of Gut-Brain Interaction (DGBI). Recent research suggests this ‘sub-diagnostic’ group demands additional investigation and might benefit from targeted interventions, including dietary interventions.
Dietary fiber is often seen as essential for gut health. However, is it always beneficial? New research challenges this idea, highlighting that not all fibers act the same and that context, type, and dose matter.
by Konstantina Zafeiropoulou
The European regulatory landscape for microbiome-based therapies is rapidly evolving. New frameworks like the SoHO Regulation aim to harmonize safety, quality, and access across countries. This article explores the current challenges, opportunities, and expert perspectives shaping the field.
